IAK vs. IHE
Compare and contrast key facts about iShares U.S. Insurance ETF (IAK) and iShares U.S. Pharmaceuticals ETF (IHE).
IAK and IHE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. IAK is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Select Insurance Index. It was launched on May 5, 2006. IHE is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Select Pharmaceuticals Index. It was launched on May 5, 2006. Both IAK and IHE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IAK or IHE.
Performance
IAK vs. IHE - Performance Comparison
Returns By Period
In the year-to-date period, IAK achieves a 33.52% return, which is significantly higher than IHE's 10.54% return. Over the past 10 years, IAK has outperformed IHE with an annualized return of 12.49%, while IHE has yielded a comparatively lower 4.71% annualized return.
IAK
33.52%
0.44%
14.54%
37.06%
15.67%
12.49%
IHE
10.54%
-4.82%
2.10%
17.96%
8.12%
4.71%
Key characteristics
| IAK | IHE | |
|---|---|---|
| Sharpe Ratio | 2.65 | 1.45 |
| Sortino Ratio | 3.48 | 2.11 |
| Omega Ratio | 1.48 | 1.25 |
| Calmar Ratio | 5.73 | 1.57 |
| Martin Ratio | 16.72 | 5.03 |
| Ulcer Index | 2.29% | 3.53% |
| Daily Std Dev | 14.49% | 12.21% |
| Max Drawdown | -77.38% | -38.20% |
| Current Drawdown | -0.88% | -7.03% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
IAK vs. IHE - Expense Ratio Comparison
IAK has a 0.43% expense ratio, which is higher than IHE's 0.42% expense ratio.
Correlation
The correlation between IAK and IHE is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
IAK vs. IHE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Insurance ETF (IAK) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IAK vs. IHE - Dividend Comparison
IAK's dividend yield for the trailing twelve months is around 1.20%, less than IHE's 1.58% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IAK iShares U.S. Insurance ETF | 1.20% | 1.44% | 1.69% | 2.26% | 2.07% | 1.84% | 2.33% | 1.62% | 1.68% | 1.62% | 1.57% | 1.14% |
IHE iShares U.S. Pharmaceuticals ETF | 1.58% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% | 1.20% | 1.06% |
Drawdowns
IAK vs. IHE - Drawdown Comparison
The maximum IAK drawdown since its inception was -77.38%, which is greater than IHE's maximum drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for IAK and IHE. For additional features, visit the drawdowns tool.
Volatility
IAK vs. IHE - Volatility Comparison
iShares U.S. Insurance ETF (IAK) has a higher volatility of 5.83% compared to iShares U.S. Pharmaceuticals ETF (IHE) at 4.28%. This indicates that IAK's price experiences larger fluctuations and is considered to be riskier than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.